Megan R Haymart, MD
Metabolism, Endocrinology, and Diabetes and Hematology/Oncology
2800 Plymouth Rd., Bldg. 16, Rm. 408E
Ann Arbor, MI 48109-2800
Manage Your Profile
About
Megan R. Haymart, MD is Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan. She holds the Nancy Wigginton Endocrinology Research Professorship of Thyroid Cancer and is Director of Thyroid Cancer Research at the University of Michigan. Dr. Haymart received her medical degree at Johns Hopkins University School of Medicine and completed her internal medicine residency at Johns Hopkins Hospital. She then completed a fellowship in endocrinology, diabetes, and metabolism at the University of Wisconsin. She has been faculty at the University of Michigan since 2009.
Dr. Haymart has a history of NIH-funded research focused on optimizing thyroid care delivery. She is a health services researcher who primarily studies thyroid cancer care across the disease continuum: from the diagnosis of a thyroid nodule to cancer survivorship. In recognition of her research, she received the American Thyroid Association’s Van Meter Award for outstanding contributions to research on the thyroid gland (2017), the University of Michigan’s Jerome Conn Award for Research Excellence (2017), membership to American Society for Clinical Investigation (2018), the AACE Hossein Gharib Education Lectureship Award for exemplary contributions to an individual profession or area of expertise (2021), and the inaugural AACE Endocrine Care Innovation Award in recognition of her team’s outstanding body of work focused on clinical outcomes or health care delivery (2025).
Dr. Haymart is actively involved in improving research infrastructure at the University of Michigan. This includes her roles as Assistant Director of Data Solutions for AI & Digital Health Innovation, faculty support for MICHR, and co-Director of Patient’s First. She also devotes time to mentoring junior faculty and trainees resulting in her receipt of the MICHR Distinguished Clinical and Translational Research Mentor Award (2021) and the Women in Thyroidology and American Thyroid Association Woman of the Year Award (2021) for promoting the advancement of women, both within the organization and field.
Links
ThyCARE (Thyroid and Thyroid CAncer REsearch)
Qualifications
-
Endocrinology, Diabetes, and Metabolism FellowshipUniversity of Wisconsin, Madison, United States
2005 - 2007
-
Internal Medicine Internship and ResidencyJohns Hopkins Hospital, Baltimore, United States
2002 - 2005
-
Doctor of MedicineThe Johns Hopkins Hospital University School of Medicine, 733 North Broadway, Baltimore, MD, 21205, United States
1998 - 2002
-
Bachelor of Arts, Interdisciplinary Major (Biology, Chemistry, Art)University of Missouri, Columbia, MO, summa cum laude, United States
1994 - 1998
Center Memberships
-
Center MemberCaswell Diabetes Institute
-
Center Membere-Health and Artificial Intelligence Initiative
-
Center MemberAI and Digital Health Innovation
-
Center MemberInstitute for Healthcare Policy and Innovation
-
Center MemberRogel Cancer Center
Research Overview
1. Optimizing cancer care delivery.
2. Understanding and addressing thyroid cancer overdiagnosis and overtreatment.
3. Addressing psychosocial concerns of cancer survivors.
Recent Publications
-
Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR. Lancet, 2023 May 6; 401 (10387): 1531 - 1544.Journal ArticleThyroid cancer.
DOI:10.1016/S0140-6736(23)00020-X PMID: 37023783 -
Wallner LP, Reyes-Gastelum D, Hamilton AS, Ward KC, Hawley ST, Haymart MR. J Clin Oncol, 2019 Aug 20; 37 (24): 2152 - 2161.Journal ArticlePatient-Perceived Lack of Choice in Receipt of Radioactive Iodine for Treatment of Differentiated Thyroid Cancer.
DOI:10.1200/JCO.18.02228 PMID: PMC6698919 -
Papaleontiou M, Reyes-Gastelum D, Gay BL, Ward KC, Hamilton AS, Hawley ST, Haymart MR. Thyroid, 2019 Aug; 29 (8): 1080 - 1088.Journal ArticleWorry in Thyroid Cancer Survivors with a Favorable Prognosis.
DOI:10.1089/thy.2019.0163 PMID: PMC6707035 -
Evron JM, Reyes-Gastelum D, Banerjee M, Scherer LD, Wallner LP, Hamilton AS, Ward KC, Hawley ST, Zikmund-Fisher BJ, Haymart MR. J Clin Oncol, 2019 Nov 10; 37 (32): 3042 - 3049.Journal ArticleRole of Patient Maximizing-Minimizing Preferences in Thyroid Cancer Surveillance.
DOI:10.1200/JCO.19.01411 PMID: PMC6839910 -
Haymart MR, Banerjee M, Reyes-Gastelum D, Caoili E, Norton EC. J Clin Endocrinol Metab, 2019 Mar 1; 104 (3): 785 - 792.Journal ArticleThyroid Ultrasound and the Increase in Diagnosis of Low-Risk Thyroid Cancer.
DOI:10.1210/jc.2018-01933 PMID: PMC6456891 -
Haymart MR, Miller DC, Hawley ST. N Engl J Med, 2017 Jul 20; 377 (3): 203 - 206.Journal ArticleActive Surveillance for Low-Risk Cancers - A Viable Solution to Overtreatment?
DOI:10.1056/NEJMp1703787 PMID: PMC5921045 -
Banerjee M, Wiebel JL, Guo C, Gay B, Haymart MR. BMJ, 2016 Jul 20; 354: i3839Journal ArticleUse of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence.
DOI:10.1136/bmj.i3839 PMID: PMC4955794 -
Haymart MR, Banerjee M, Stewart AK, Koenig RJ, Birkmeyer JD, Griggs JJ. JAMA, 2011 Aug 17; 306 (7): 721 - 728.Journal ArticleUse of radioactive iodine for thyroid cancer.
DOI:10.1001/jama.2011.1139 PMID: PMC3352591
Featured News & Stories
Closing the Gap
Drs. Megan Haymart and Maria Papaleontiou Receive Prestigious American Thyroid Association Awards
2 Rogel members recognized by American Thyroid Association
Study Finds Online Language Barriers Persist in Health Care
Language barriers in health care have fallen – but not online, study shows